Neumora Therapeutics, Inc. Common Stock Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 3 | -$0.37 | -$0.37 | -$0.37 |
Q2 2024 | 5 | -$0.43 | -$0.37 | -$0.39 |
Q3 2024 | 3 | -$0.37 | -$0.37 | -$0.37 |
Q1 2025 | 4 | -$0.38 | -$0.38 | -$0.38 |
Q2 2025 | 4 | -$0.38 | -$0.38 | -$0.38 |
Q3 2025 | 4 | -$0.38 | -$0.38 | -$0.38 |
Q4 2025 | 4 | -$0.38 | -$0.38 | -$0.38 |
Neumora Therapeutics, Inc. Common Stock Earnings Date And Information
Neumora Therapeutics, Inc. Common Stock last posted its earnings results on Tuesday, August 6th, 2024. The company reported $-0.37 earnings per share for the quarter, missing analysts' consensus estimates of $-0.37 by $0. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Neumora Therapeutics, Inc. Common Stock has generated $-1 earnings per share over the last year ($-1.49 diluted earnings per share) and currently has a price-to-earnings ratio of -7.9. Neumora Therapeutics, Inc. Common Stock has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, October 30th, 2024 based on prior year's report dates.
Neumora Therapeutics, Inc. Common Stock Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
08/06/2024 | Q2 2024 | -$0.37 | -$0.37 | 0 | $0 | $0 |
05/07/2024 | Q1 2024 | -$0.35 | -$0.34 | 0.01 | $0 | |
03/07/2024 | Q4 2023 | -$0.65 | -$0.68 | -0.03 | $0 | |
11/01/2023 | Q3 2023 | -$0.36 | -$0.34 | 0.02 | $0 | |
06/29/2023 | Q2 2023 | -$0.25 | $0 | |||
03/30/2023 | Q1 2023 | -$0.23 | $0 | |||
12/30/2022 | Q4 2022 | -$0.19 | $0 | |||
09/29/2022 | Q3 2022 | -$0.19 | $0 | |||
06/29/2022 | Q2 2022 | -$0.20 | $0 | |||
03/30/2022 | Q1 2022 | -$0.28 | $0 | |||
12/30/2021 | Q4 2021 | -$0.18 | $0 | |||
09/29/2021 | Q3 2021 | -$1.17 | $0 | |||
06/29/2021 | Q2 2021 | -$0.11 | $0 | |||
03/30/2021 | Q1 2021 | -$0.10 | $0 | |||
12/30/2020 | Q4 2020 | -$0.13 | $0 |
Neumora Therapeutics, Inc. Common Stock Earnings: Frequently Asked Questions
-
When is Neumora Therapeutics, Inc. Common Stock's earnings date?
Neumora Therapeutics, Inc. Common Stock has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, October 30th, 2024 based off last year's report dates.
-
How can I listen to Neumora Therapeutics, Inc. Common Stock's earnings conference call?
The conference call for Neumora Therapeutics, Inc. Common Stock's latest earnings report can be listened to online.
-
How can I read Neumora Therapeutics, Inc. Common Stock's conference call transcript?
The conference call transcript for Neumora Therapeutics, Inc. Common Stock's latest earnings report can be read online.
-
How much profit does Neumora Therapeutics, Inc. Common Stock generate each year?
Neumora Therapeutics, Inc. Common Stock (:NMRA) has a recorded net income of $0. Neumora Therapeutics, Inc. Common Stock has generated $-1.49 earnings per share over the last four quarters.
-
What is Neumora Therapeutics, Inc. Common Stock's price-to-earnings ratio?
Neumora Therapeutics, Inc. Common Stock (:NMRA) has a price-to-earnings ratio of -7.9 and price/earnings-to-growth ratio is 0.11.